OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
TSMC Posts Record Q1 Profit Fueled by AI Chip Demand 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Want to cut your energy bills? Here’s how five experts are doing it 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
SAN FRANCISCO, May 30, 2017 -- Invuity, Inc. (NASDAQ:IVTY), an advanced surgical illumination company focused on minimal access surgery, today announced that company management is scheduled to present at the William Blair 37th Annual Growth Stock Conference on June 13, 2017 at 2:10 p.m. Central Time in Chicago.
A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors & Media. A replay of the webcast will be available shortly after the conclusion of the presentation and will be archived on the Company's website for 30 days following the presentation.
About Invuity®
Invuity, Inc. is a leading medical technology company focused on developing and marketing advanced surgical devices to improve the ability of physicians to perform minimal access surgery through smaller and hidden incisions. The company's proprietary Intelligent Photonics™ technology delivers enhanced visualization which facilitates surgical precision, efficiency and safety. In addition, the company utilizes comprehensive strategic marketing programs to create stronger institutional partnerships. Clinical applications include women’s health, encompassing breast cancer and breast reconstruction surgery, gynecology and thyroid surgery. Additional applications include procedures for electrophysiology, spine, orthopedic, cardiothoracic, and general surgery. Invuity is headquartered in San Francisco, CA. For more information, visit www.invuity.com.
CONTACT: Company Contact: Jim Mackaness Chief Financial Officer Invuity, Inc. 415-655-2129 Investors: Mark Klausner Westwicke Partners 443-213-0501 [email protected]
